<DOC>
	<DOCNO>NCT00570011</DOCNO>
	<brief_summary>An international study patient GHD randomize receive somatropin dose either 3 microg/kg/day 6 microg/kg/day first three month . The dose double ( 6 microg/kg/day , LD 12 microg/kg/day , CD ) next three-months .</brief_summary>
	<brief_title>Low Conventional Dose Somatropin Growth Hormone Deficient Adult Patients</brief_title>
	<detailed_description />
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Patients may include study meet follow criterion : 1 . Adult male female GHD , arise adult life pituitary ablation failure , onset GHD take place least 1 year enter study , , 2 . Adult male females GHD either idiopathic secondary pituitary disease arise childhood . 3 . Demonstrated GHD document negative response standard GH stimulation test within last 5 year previous year ( see Section 3.4.3 , part b ) . Maximal peak must less 3.0 ng/ml . 4 . Receiving replacement deficient hormone least 3 month prior start study , necessary . 5 . Have give informed consent . Patients exclude study follow reason : 1 . Patients clinically significant pulmonary , cardiac , hepatic , renal neuromuscular disease chromosomal genetic malformation syndrome . 2 . Patients evidence active tumorous process . Intercranial lesion must inactive antitumour therapy must complete . 3 . Pregnant woman lactate female woman decide become pregnant study take adequate contraceptive . 4 . Patients think unlikely comply protocol . 5 . Patients take investigational drug previous month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>